In an exchange filing, Wockhardt said: "The NDA was originally filed on September 30, 2025, and its acceptance marks a transformative moment -- not only for Wockhardt, but also for the entire Indian ...
News-Medical.Net on MSN
Study elucidates how anti-amyloid antibody therapy lecanemab works in Alzheimer's disease
Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback